Agc Biologics

AGC Biologics is a global contract development and manufacturing organization (CDMO) specializing in the development and production of biopharmaceuticals. They provide comprehensive services from early-stage development to commercial manufacturing, including cell line development, process development, and analytical testing. The company generates revenue by partnering with pharmaceutical and biotechnology firms to bring innovative therapies to market. Founded in 2017 through the merger of Asahi Glass Company’s Biologics division and CMC Biologics, AGC Biologics has a rich history of expertise and a strong commitment to quality and innovation in the biopharmaceutical industry.

Recent Posts by Agc Biologics

1-20 of 75